Stryker Corp
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 months.
- Recent price momentum is -9.4% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 1.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 33.0x | Better than 19% |
| Forward P/E | 21.7x | Better than 31% |
| Price / Sales | 4.5x | Better than 26% |
| P/E vs own 5-yr range | 4th pctl | Better than 96% |
Growth A-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 10.8% | Better than 66% |
| Net income CAGR (3Y) | 11.2% | Better than 61% |
| Free cash flow CAGR (3Y) | 28.1% | Better than 73% |
Profitability A-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 64.0% | Better than 78% |
| Operating margin | 20.1% | Better than 76% |
| Net margin | 12.9% | Better than 67% |
| Return on equity | 15.1% | Better than 68% |
| Return on invested capital | 10.2% | Better than 68% |
Momentum B-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -5.9% | Better than 60% |
| 6-month return | -1.8% | Better than 52% |
| 12-month return (ex latest month) | -15.9% | Better than 18% |
| Distance below 52-week high | 19.7% | Better than 61% |
Financial Health B
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.9x | Better than 53% |
| Debt to assets | 33.1% | Better than 36% |
| Interest coverage | 8.4x | Better than 69% |
| Free cash flow / net income | 131.9% | Better than 58% |
Analyst View C+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 85.7% | Better than 67% |
| Upside to average target | 11.0% | Better than 15% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 313.08
- Open
- 317.68
- Day range
- 308.82 - 320.97
- Avg price
- 312.74
- Volume
- 2.38M
- Turnover
- 745.35M
- Turnover ratei
- 0.69%
- Volume ratioi
- 0.75
- Amplitudei
- 3.88%
- 52-week rangei
- 266.16 - 386.02
Valuation
- P/Ei
- 36.90
- P/E (TTM)i
- 33.01
- P/Bi
- 5.03
- EPSi
- 8.40
- Book value / shi
- 61.62
- Net profit
- 3.20B
- Net assets
- 23.46B
Share structure
- Market cap
- 118.01B
- Float capi
- 107.21B
- Shares out
- 380.69M
- Float sharesi
- 345.82M
Dividend & listing
- Div yield (TTM)i
- 1.14%
- Dividend (TTM)
- 3.52
- Listing date
- 1970-01-01
19.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-116.39M net over the window
Short interest
- Shares short
- 6.66M
- % of floati
- 1.74%
- Days to coveri
- 2.23
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Stryker Corp (SYK)?
Stryker Corp last traded at 310.00. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Stryker Corp's market cap?
About 118.01B.
What is the P/E ratio of Stryker Corp?
The trailing twelve-month P/E is 33.01, below its own 5-year average of 42.65 — toward the bottom of its historical range (3.98% percentile). See the Valuation tab for the full history.
Does Stryker Corp pay a dividend?
Yes. The trailing dividend yield is 1.14%. The 2025 payout was up 4.9% from 2024. See the Dividends tab for the full payment history.
Is Stryker Corp a buy according to analysts?
The consensus of 21 analysts is a Buy rating, with an average 12-month price target of 344.05, which implies 11.0% upside from the current price. This is not investment advice.
What is Stryker Corp's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Stryker Corp a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:31:25 · For reference only, not investment advice and not tailored to your situation.
Stryker Corp discussion 0 comments